Point72 Asset Management’s Heron Therapeutics HRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,775,877
Closed -$10.5M 1549
2025
Q1
$10.5M Buy
4,775,877
+1,700,068
+55% +$3.74M 0.02% 523
2024
Q4
$4.71M Buy
+3,075,809
New +$4.71M 0.01% 682
2024
Q2
Sell
-5,600
Closed -$15.5K 1438
2024
Q1
$15.5K Buy
+5,600
New +$15.5K ﹤0.01% 1377
2023
Q3
Sell
-22
Closed -$26 1939
2023
Q2
$26 Sell
22
-34,012
-100% -$40.2K ﹤0.01% 1554
2023
Q1
$51.4K Buy
+34,034
New +$51.4K ﹤0.01% 1265
2022
Q4
Hold
0
1234
2021
Q4
Sell
-1,600,486
Closed -$17.1M 1117
2021
Q3
$17.1M Buy
1,600,486
+1,357,037
+557% +$14.5M 0.08% 330
2021
Q2
$3.78M Buy
243,449
+178,449
+275% +$2.77M 0.02% 610
2021
Q1
$1.05M Sell
65,000
-45,382
-41% -$736K ﹤0.01% 744
2020
Q4
$2.34M Sell
110,382
-150,959
-58% -$3.19M 0.01% 667
2020
Q3
$3.87M Buy
+261,341
New +$3.87M 0.02% 571
2019
Q2
Sell
-173,700
Closed -$4.25M 1314
2019
Q1
$4.25M Buy
+173,700
New +$4.25M 0.02% 509
2018
Q3
Sell
-20,000
Closed -$777K 927
2018
Q2
$777K Buy
+20,000
New +$777K ﹤0.01% 690
2017
Q2
Sell
-133,483
Closed -$2M 786
2017
Q1
$2M Buy
+133,483
New +$2M 0.01% 598
2015
Q4
Sell
-1,100
Closed -$27K 692
2015
Q3
$27K Sell
1,100
-250,400
-100% -$6.15M ﹤0.01% 667
2015
Q2
$7.84M Sell
251,500
-248,500
-50% -$7.74M 0.05% 346
2015
Q1
$7.28M Sell
500,000
-10,100
-2% -$147K 0.05% 359
2014
Q4
$5.13M Buy
+510,100
New +$5.13M 0.04% 402